BRPI1006374A2 - "processo para a preparação de etoricoxib, composto, processo para a purificação de etoricoxib, forma polimórfica, etoricoxib" - Google Patents
"processo para a preparação de etoricoxib, composto, processo para a purificação de etoricoxib, forma polimórfica, etoricoxib"Info
- Publication number
- BRPI1006374A2 BRPI1006374A2 BRPI1006374A BRPI1006374A BRPI1006374A2 BR PI1006374 A2 BRPI1006374 A2 BR PI1006374A2 BR PI1006374 A BRPI1006374 A BR PI1006374A BR PI1006374 A BRPI1006374 A BR PI1006374A BR PI1006374 A2 BRPI1006374 A2 BR PI1006374A2
- Authority
- BR
- Brazil
- Prior art keywords
- etoricoxib
- purification
- compound
- preparation
- polymorphic form
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN441MU2009 | 2009-02-27 | ||
PCT/IN2010/000045 WO2010097802A2 (en) | 2009-02-27 | 2010-01-25 | A process for the preparation of etoricoxib |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1006374A2 true BRPI1006374A2 (pt) | 2019-09-24 |
Family
ID=42290121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1006374A BRPI1006374A2 (pt) | 2009-02-27 | 2010-01-25 | "processo para a preparação de etoricoxib, composto, processo para a purificação de etoricoxib, forma polimórfica, etoricoxib" |
Country Status (10)
Country | Link |
---|---|
EP (2) | EP2479166B1 (pt) |
AR (1) | AR075441A1 (pt) |
BR (1) | BRPI1006374A2 (pt) |
DK (2) | DK2479166T3 (pt) |
ES (2) | ES2562981T3 (pt) |
HU (1) | HUE028730T2 (pt) |
MY (1) | MY163020A (pt) |
PL (2) | PL2401253T3 (pt) |
PT (1) | PT2479166E (pt) |
WO (1) | WO2010097802A2 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012066570A2 (en) | 2010-11-15 | 2012-05-24 | Virdev Intermediates Pvt. Ltd. | A process for cyclooxygenase-2 selective inhibitor |
EA023286B1 (ru) * | 2011-05-27 | 2016-05-31 | ФАРМА ДжРС, Д.О.О. | Способ получения полиморфной формы i эторикоксиба |
EP2773618A1 (en) | 2011-11-03 | 2014-09-10 | Cadila Healthcare Limited | An improved process for the preparation of etoricoxib and polymorphs thereof |
GR1007973B (el) * | 2012-06-26 | 2013-09-12 | Φαρματεν Αβεε, | Νεα ν-οξοιμινο παραγωγα ως ενδιαμεσα μιας βελτιωμενης μεθοδου παρασκευης 2,3-διαρυλο-5-υποκατεστημενων πυριδινων |
WO2014114352A1 (en) * | 2013-01-25 | 2014-07-31 | Synthon Bv | Process for making etoricoxib |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5593994A (en) | 1994-09-29 | 1997-01-14 | The Dupont Merck Pharmaceutical Company | Prostaglandin synthase inhibitors |
US5739166A (en) | 1994-11-29 | 1998-04-14 | G.D. Searle & Co. | Substituted terphenyl compounds for the treatment of inflammation |
SI0912518T1 (en) | 1996-07-18 | 2003-12-31 | Merck Frosst Canada & Co. | Substituted pyridines as selective cyclooxygenase-2 inhibitors |
US5861419A (en) | 1996-07-18 | 1999-01-19 | Merck Frosst Canad, Inc. | Substituted pyridines as selective cyclooxygenase-2 inhibitors |
AU759469B2 (en) | 1998-04-24 | 2003-04-17 | Merck Sharp & Dohme Corp. | Process for synthesizing cox-2 inhibitors |
EP1248618B1 (en) | 1999-11-29 | 2006-03-22 | Merck Frosst Canada Inc. | Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- 2,3']bipyridinyl |
PH12001001175B1 (en) | 2000-05-26 | 2006-08-10 | Merck Sharp & Dohme | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- (2,3')bipyridinyl in pure crystalline form and process for synthesis |
US6521642B2 (en) | 2000-05-26 | 2003-02-18 | Merck & Co., Inc. | 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl in pure crystalline form and process for synthesis |
JP2003160563A (ja) * | 2001-11-29 | 2003-06-03 | Sankio Chemical Co Ltd | 新規な3−アミノ−2−プロペニリデンアンモニウム誘導体・bf4塩 |
WO2005085199A1 (en) | 2004-01-14 | 2005-09-15 | Cadila Healthcare Limited | Novel polymorphs of etoricoxib |
-
2010
- 2010-01-25 PT PT121625586T patent/PT2479166E/pt unknown
- 2010-01-25 ES ES10719784.0T patent/ES2562981T3/es active Active
- 2010-01-25 EP EP12162558.6A patent/EP2479166B1/en not_active Not-in-force
- 2010-01-25 ES ES12162558.6T patent/ES2496465T3/es active Active
- 2010-01-25 HU HUE10719784A patent/HUE028730T2/en unknown
- 2010-01-25 PL PL10719784T patent/PL2401253T3/pl unknown
- 2010-01-25 MY MYPI2011003123A patent/MY163020A/en unknown
- 2010-01-25 EP EP10719784.0A patent/EP2401253B1/en active Active
- 2010-01-25 DK DK12162558.6T patent/DK2479166T3/da active
- 2010-01-25 WO PCT/IN2010/000045 patent/WO2010097802A2/en active Application Filing
- 2010-01-25 BR BRPI1006374A patent/BRPI1006374A2/pt not_active IP Right Cessation
- 2010-01-25 PL PL12162558T patent/PL2479166T3/pl unknown
- 2010-01-25 DK DK10719784.0T patent/DK2401253T3/en active
- 2010-02-16 AR ARP100100449A patent/AR075441A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUE028730T2 (en) | 2017-01-30 |
DK2401253T3 (en) | 2016-04-18 |
ES2562981T3 (es) | 2016-03-09 |
WO2010097802A3 (en) | 2010-12-23 |
WO2010097802A2 (en) | 2010-09-02 |
MY163020A (en) | 2017-07-31 |
EP2401253B1 (en) | 2016-01-13 |
EP2401253A2 (en) | 2012-01-04 |
EP2479166A1 (en) | 2012-07-25 |
EP2479166B1 (en) | 2014-08-20 |
PL2401253T3 (pl) | 2016-05-31 |
DK2479166T3 (da) | 2014-09-01 |
PL2479166T3 (pl) | 2014-11-28 |
PT2479166E (pt) | 2014-11-28 |
ES2496465T3 (es) | 2014-09-19 |
AR075441A1 (es) | 2011-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0911254A2 (pt) | processo para a preparação de um composto | |
BR112013002925A2 (pt) | processo para a síntese de ácido 2,5-furandicarboxílico | |
BRPI1010128A2 (pt) | "processo para a fabricação do 2,3,3,3 - tetrafluropropeno" | |
BR112012014490A2 (pt) | processo para a preparação substituída de 1-o-acil-2-desóxi-2-fluoro-4-tio-beta-d-arabinofuranoses | |
BRPI1015061A2 (pt) | "processo para a preparação contínua de isocianatos" | |
BRPI1012370A2 (pt) | processo para a produção de olefinas | |
BRPI0815784A2 (pt) | Processo para a preparação de 1,2-propanodiol | |
BRPI1006679A2 (pt) | "processo para a preparação de um composto de estireno halogenado" | |
BRPI0915572A2 (pt) | processo para a fabricação de epicloroidrina | |
BRPI0911897A2 (pt) | Processo para a preparação de compostos, e, composto | |
BRPI0809652A2 (pt) | Processo melhorado para a síntese de solifenacina | |
BRPI1013830A2 (pt) | Processo para a iodação de compostos aromáticos | |
BRPI0817747A2 (pt) | Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico | |
BRPI1008117A2 (pt) | Processo para a sintese de cleistantina | |
BRPI0821837A2 (pt) | Processo para a preparação de 6-substituídas-1-(2h)-isoquinolinonas | |
BRPI0920705A8 (pt) | processo para a produção de compostos alquilaromáticos | |
BR112012001731A2 (pt) | Processo para a preparação de 1-benzil-3-hidroximetil-1h-indazol | |
BRPI1006374A2 (pt) | "processo para a preparação de etoricoxib, composto, processo para a purificação de etoricoxib, forma polimórfica, etoricoxib" | |
BRPI1010571A2 (pt) | processo para a preparação de um composto útil como um inibidor de tafla. | |
BRPI0815971A2 (pt) | Processo para a preparação de 1,2-propanodiol | |
BRPI0921210A2 (pt) | processos para a preparação de compostos de arilaminas | |
BRPI0914792A2 (pt) | processo para a preparação de polióis | |
BR112012009611A2 (pt) | ''processo para a preparação de um composto de fómula (i)'' | |
BRPI0914400A2 (pt) | "processo para a síntese de um composto" | |
BRPI0910595A2 (pt) | processo para a produção de composto de pirimidina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law | ||
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |